Comparing two versions of an injected drug in healthy and overweight people
Part of Hormones & metabolism clinical trials.
This trial compares two different versions of an injected study drug (survodutide) to see how they are absorbed by the body. It is open to healthy people and people with overweight or obesity, and it may help researchers find a better way to deliver this treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 55 years old.
- You are generally healthy, or you have overweight or obesity.
- Your body mass index (BMI) is between 22 and 39.9.
- You are willing to give written informed consent.
- You have no major health conditions that are not well controlled.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new drug called BI 3034701 to see how well people tolerate different doses. It may help with weight loss and related health issues.
This study tests an investigational medicine called survodutide to help adults with overweight or obesity lose weight. If you have tried to lose weight before with diet but haven't had lasting success, you may be able to join.
This trial tests two similar versions of an injected study drug to see if they are equally safe and how the body processes them. It is for healthy volunteers only, not for treating a disease.
This study tests a new injected medicine (called HS-20136-2) to see if it is safe and how the body handles it. It is an early (phase 1) trial that includes healthy people and people with overweight, and the goal is to learn about possible effects on weight and metabolism.
This study tests a new medicine called survodutide to see if it can improve heart function and structure in people who are overweight and have fatty liver disease. It may help reduce risks related to heart problems.
This study tests an investigational drug called survodutide to see if it helps women who are overweight or obese and going through or finished menopause lose weight. If you qualify, you may receive the study drug or a placebo, and the study will track your weight loss over time.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.